Form 4: Teladoc Health Director Jason Eric Evans Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Jason Eric Evans reported the vesting and disposal of restricted stock units of Teladoc Health, Inc. on March 20, 2025.

Summary

  • On March 20, 2025, Jason Eric Evans, a director of Teladoc Health, Inc., reported transactions involving restricted stock units.
  • Evans acquired 1,016 shares of common stock through the vesting of restricted stock units.
  • Simultaneously, Evans disposed of 1,016 shares of common stock.
  • Following these transactions, Evans directly owns 6,097 shares of common stock and 6,098 restricted stock units.
  • The restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • These restricted stock units were granted on September 20, 2023, and vest over time.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by a company director, with no inherent positive or negative implications.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, like directors, who trade in their company's stock. It provides transparency to the market regarding the transactions of those with privileged information.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding insider transactions.

Key Dates

DateDescription
09/20/2023Reporting person was granted 12,195 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
03/20/2025Date of transaction: vesting of restricted stock units and disposal of shares.
03/21/2025Date of signature for the Form 4 filing.

Keywords

Teladoc Health, TDOC, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, Beneficial Ownership, Director, Jason Eric Evans

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.